235
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

N-Cadherin Expression with Metastasis of Neck Lymph Nodes in Patients with Nasopharyngeal Carcinoma

ORCID Icon, , , ORCID Icon, & ORCID Icon
Pages 1029-1037 | Received 21 Nov 2022, Accepted 14 Mar 2023, Published online: 21 Mar 2023

References

  • Chiang CL, Guo Q, Ng WT, et al. Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: a systematic review of the literature. Front Oncol. 2021;11. doi:10.3389/fonc.2021.703995
  • Fles R, Indrasari SR, Herdini C, et al. Effectiveness of a multicentre nasopharyngeal carcinoma awareness programme in Indonesia. BMJ Open. 2016;6(3):e008571. doi:10.1136/bmjopen-2015-008571
  • Xu Y, Huang T, Fan L, Jin W, Chen X, Chen J. Patterns and prognostic value of lymph node metastasis on distant metastasis and survival in nasopharyngeal carcinoma: a surveillance, epidemiology, and end results study, 2006–2015. J Oncol. 2019;2019:1.
  • Luo W. Nasopharyngeal Carcinoma Ecology Theory: cancer as Multi- dimensional Spatiotemporal “Unity of Ecology and Evolution” Pathological Ecosystem. MDPI; 2022.
  • Liu M-T, Chen M-K, Huang -C-C, Huang C-Y. Prognostic value of molecular markers and implication for molecular targeted therapies in nasopharyngeal carcinoma: an update in an era of new targeted molecules development. World J Oncol. 2015;6(1):243–261. doi:10.14740/wjon610w
  • Yu W, Yang L, Li T, Zhang Y. Cadherin signaling in cancer: its functions and role as a therapeutic target. Front Oncol. 2019;9. doi:10.3389/fonc.2019.00989
  • Cao Z, Wang Z, Leng P. Biomedicine & Pharmacotherapy Aberrant N-cadherin expression in cancer. Biomed Pharmacother. 2019;118(16):109320. doi:10.1016/j.biopha.2019.109320
  • Mrozik KM, Blaschuk OW, Cheong CM, Zannettino ACW, Vandyke K. N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 2018;18(1):1–16. doi:10.1186/s12885-018-4845-0
  • Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci. 2008;121(6):727–735. doi:10.1242/jcs.000455
  • Breier G, Grosser M, Rezaei M. Endothelial cadherins in cancer. Cell Tissue Res. 2014;355(3):523–527. doi:10.1007/s00441-014-1851-7
  • Lou PJ, Chen WP, Lin CT, DePhilip RM, Wu JC. E-, P-, and N-cadherin are Co-expressed in the nasopharyngeal carcinoma cell line TW-039. J Cell Biochem. 2000;76(1):161–172. doi:10.1002/(SICI)1097-4644(20000101)76:1<161::AID-JCB16>3.0.CO;2-W
  • Liu Q, Wang Y, Jing S-H, Wang X-L, Cheng Y-J, Wu F-P. [Expression of E-cadherin in nasopharyngeal carcinoma and its relationship with cervical lymph node metastasis]. Zhonghua Zhong Liu Za Zhi. 2010;32(6):425–428. Chinese.
  • Sun H, Liu M, Wu X, Yang C, Zhang YXZ. Overexpression of N-cadherin and β-catenin correlates with poor prognosis in patients with nasopharyngeal carcinoma. Oncol Lett. 2017;13(3):725–730. doi:10.3892/ol.2017.5645
  • Luo W, Yao K. Molecular characterization and clinical implications of spindle cells in nasopharyngeal carcinoma: a novel molecule-morphology model of tumor progression proposed. PLoS One. 2013;8(12):1–12. doi:10.1371/journal.pone.0083135
  • Browner WS, Newman TB, Hulley S. Estimating sample size and power: applications and examples. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB, editors. Designing Clinical Research. Philadelphia, PA USA: Lippincott Williams and Wilkins; 2013:1–6.
  • Luo WR, Wu AB, Fang WY, Li SY, Yao KT. Nuclear expression of N-cadherin correlates with poor prognosis of nasopharyngeal carcinoma. Histopathology. 2012;61(2):237–246. doi:10.1111/j.1365-2559.2012.04212.x
  • Romdhoni AC, Aulia R, Utaminingtyas RP, Suharjono Alderman CP. Correlation of chemotherapy costs with quality of life in nasopharyngeal cancer patients. J Basic Clin Physiol Pharmacol. 2019;30:6.
  • Chou J, Lin Y-C, Kim J, et al. Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis. Head Neck. 2008;30(7):946–963. doi:10.1002/hed.20833
  • Amelia FI, Yusuf M. Correlation Between ß-catenin expression and staging in nasopharyngeal carcinoma patients. Indian J Otolaryngol Head Neck Surg. 2019;71(Suppl 1):384–389.
  • Morandi A, Taddei ML, Chiarugi P, Giannoni E. Targeting the metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors. Front Oncol. 2017;7:1–19. doi:10.3389/fonc.2017.00040
  • Vergara D, Simeone P, Franck J, et al. Translating epithelial mesenchymal transition markers into the clinic: novel insights from proteomics. EuPA Open Proteomics. 2016;10:31–41. doi:10.1016/j.euprot.2016.01.003
  • Hsu -C-C, Huang S-F, Wang J-S, et al. Interplay of N-Cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion. BMC Cancer. 2016;16(1):800. doi:10.1186/s12885-016-2846-4
  • Paduch R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. 2016;39(5):397–410. doi:10.1007/s13402-016-0281-9
  • Mariotti A, Perotti A, Sessa C, Rüegg C. N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs. 2007;16(4):451–465. doi:10.1517/13543784.16.4.451
  • Kentjono WA. Perkembangan terkini penatalaksanaan karsinoma nasofaring [Recent developments in the management of NPC Tropical medicine magazine]. Majalah Kedoteran Tropis Indonesia; 2003:1–39.
  • Hwang JM, Fu KK, Phillips TL. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1998;41(5):1099–1111. doi:10.1016/S0360-3016(98)00164-3
  • Debnath P, Huirem RS, Dutta P, Palchaudhuri S. Epithelial-mesenchymal transition and its transcription factors. Biosci Rep. 2022;42:1. doi:10.1042/BSR20211754